Accurate staging is very important for determining a prognosis and appropriate treatment for malignant melanoma (MM). The aim of this study is to determine the effectiveness of PET/CT imaging in staging MM. Patients diagnosed with MM who then underwent PET/CT metastasis before treatment were assessed retrospectively. For each patient, the following variables were recorded: Breslow thickness, Clark’s level, number of mitoses and presence of ulceration detected in the pathology report and the presence of lymph nodes and/or distant metastases detected by PET/CT. The pathology and PET/CT reports of 139 patients (79 female and 60 male) were retrospectively evaluated for staging after MM diagnosis. Patients with a Breslow thickness greater than 3.4 mm and Clark’s level of 4-5 were found to be statistically significantly higher with regional lymph node metastasis after PET/CT scans. Patients with Breslow thickness greater than 2.85 mm and Clark’s level of 4-5 were found to be statistically significantly higher with distant metastasis after PET/CT scan. The results of our study suggest that PET/CT imaging for metastasis scanning, starting with T2 patients, may be used in MM staging to reduce the need for SLN biopsy and lymph node dissection. This article is protected by copyright. All rights reserved.This article is protected by copyright. All rights reserved.
Effects of multicomponent primary care-based intervention on immunization rates and missed opportunities to vaccinate adults.
March 5, 2020
Promoting Reproducible Research for Characterizing Nonmedical Use of Medications Through Data Annotation: Description of a Twitter Corpus and Guidelines.
March 5, 2020
March 12, 2020
Related Meeting Coverage
- ASCO 2019The 2019 ASCO Annual Meeting, taking place May 31-June 4 in Chicago, will bring together more than 32,000 oncology professionals from across the globe. The theme of this year’s conference is Caring for Every Patient, Learning From Every Patient.